Skystar Bio-Pharmaceutical Announces Partnership With Tianlong Technology

Skystar Bio-Pharmaceutical (OTC BB: SKBI), a leading Bio-Pharmaceutical Company in China, announced a joint venture with Xi'an Tianlong Science and Technology Limited, who has developed a quick and accurate method for detecting the presence of the Avian Flu Virus.
MORE ON THIS TOPIC